For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $33.79 in the prior trading day, Harmony Biosciences Holdings Inc (NASDAQ: HRMY) closed at $33.72, down -0.21%. In other words, the price has decreased by -$0.21 from its previous closing price. On the day, 0.69 million shares were traded.
Ratios:
Our goal is to gain a better understanding of HRMY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.75. For the most recent quarter (mrq), Quick Ratio is recorded 3.63 and its Current Ratio is at 3.67. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on February 11, 2025, initiated with a Buy rating and assigned the stock a target price of $55.
On December 17, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $75.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 19 ’25 when JEFFREY G DIERKS bought 9,844 shares for $35.56 per share.
JEFFREY G DIERKS bought 2,292 shares of HRMY for $80,427 on May 16 ’25. On May 12 ’25, another insider, JEFFREY G DIERKS, who serves as the Former Officer of the company, bought 5,000 shares for $35.19 each.
Valuation Measures:
As of this moment, Harmony’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.86, and their Forward P/E ratio for the next fiscal year is 8.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.51. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.60 while its Price-to-Book (P/B) ratio in mrq is 2.69.
Stock Price History:
Over the past 52 weeks, HRMY has reached a high of $41.61, while it has fallen to a 52-week low of $26.47. The 50-Day Moving Average of the stock is 5.68%, while the 200-Day Moving Average is calculated to be -2.71%.
Shares Statistics:
A total of 57.39M shares are outstanding, with a floating share count of 43.61M. Insiders hold about 24.06% of the company’s shares, while institutions hold 78.52% stake in the company.
